BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38357928)

  • 1. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.
    D'Avola A; Legrave N; Tajan M; Chakravarty P; Shearer RL; King HW; Kluckova K; Cheung EC; Clear AJ; Gunawan AS; Zhang L; James LK; MacRae JI; Gribben JG; Calado DP; Vousden KH; Riches JC
    J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357928
    [No Abstract]   [Full Text] [Related]  

  • 2. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
    Yoon SO; Jeon YK; Paik JH; Kim WY; Kim YA; Kim JE; Kim CW
    Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma.
    Wagner SD; Amen F; Trivedi PS; Horncastle D; Elderfield K; Naresh KN
    Leuk Lymphoma; 2007 Aug; 48(8):1510-3. PubMed ID: 17701581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with
    Chapman J; Verdun RE; Lossos IS
    Leuk Lymphoma; 2021 Oct; 62(10):2547-2550. PubMed ID: 33988072
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
    J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of mTOR in germinal center and nongerminal center group of diffuse large B-cell lymphoma: a clinicopathological study.
    Vajpayee N; Burack R; Wang D; Hutchison RE; Gajra A
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):159-63. PubMed ID: 25458080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.
    Gualco G; Weiss LM; Harrington WJ; Bacchi CE
    Am J Surg Pathol; 2009 Dec; 33(12):1815-22. PubMed ID: 19816150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype preference of the BCL6397G/C polymorphism in germinal-center and non-germinal-center subtypes of diffuse large B-cell lymphoma.
    Berglund M; Amini RM; Book M; Rosenquist R; Roos G; Thunberg U
    Blood; 2006 Nov; 108(10):3623-4. PubMed ID: 17085720
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.
    Yoshida S; Nakamura N; Sasaki Y; Yoshida S; Yasuda M; Sagara H; Ohtake T; Takenoshita S; Abe M
    Mod Pathol; 2005 Mar; 18(3):398-405. PubMed ID: 15492762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
    Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
    Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.
    Miles RR; Raphael M; McCarthy K; Wotherspoon A; Lones MA; Terrier-Lacombe MJ; Patte C; Gerrard M; Auperin A; Sposto R; Davenport V; Cairo MS; Perkins SL;
    Pediatr Blood Cancer; 2008 Sep; 51(3):369-74. PubMed ID: 18493992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.
    Visco C; Tzankov A; Xu-Monette ZY; Miranda RN; Tai YC; Li Y; Liu WM; d'Amore ES; Li Y; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Wang HY; Dunphy CH; His ED; Zhao XF; Choi WW; Zhao X; van Krieken JH; Huang Q; Ai W; O'Neill S; Ponzoni M; Ferreri AJ; Kahl BS; Winter JN; Go RS; Dirnhofer S; Piris MA; Møller MB; Wu L; Medeiros LJ; Young KH
    Haematologica; 2013 Feb; 98(2):255-63. PubMed ID: 22929980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV
    Liu H; Xu-Monette ZY; Tang G; Wang W; Kim Y; Yuan J; Li Y; Chen W; Li Y; Fedoriw GY; Zhu F; Fang X; Luedke C; Medeiros LJ; Young KH; Hu S
    Histopathology; 2022 Feb; 80(3):575-588. PubMed ID: 34637146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
    Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
    Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
    J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.